Showing 15 posts of 19 posts found.


NICE recommends Daiichi Sankyo’s cholesterol-lowering treatments for NHS England use

March 18, 2021
Daiichi Sankyo, NICE, cholesterol

NICE has recommended Daiichi Sankyo’s bempedoic acid and bempedoic acid/ezetimibe for treating primary hypercholesterolaemia (heterozygous familial and non-familial) or mixed …


Women who take statins could be less likely to develop ovarian cancer, study finds

February 19, 2020
Research and Development, Sales and Marketing Cancer, Cancer Research UK, cholesterol, ovarian cancer, statins

A study by Cancer Research UK has found that women who take statins, drugs that lower cholesterol, are less likely …


NHS to pioneer Novartis injection that reduces cholesterol

January 14, 2020
Manufacturing and Production NHS, NHS England, bad cholesterol, cholesterol, heart attack

The NHS in England is pioneering a new twice-a-year injection, inclisiran, which reduces bad cholesterol.It has reached a deal with …

Half of patients have sub-optimal response to statins, research shows

April 16, 2019
Manufacturing and Production NHS, NICE, NICE guidelines, cholesterol, health, statins

Around half of patients who are prescribed statins do not see their cholesterol drop to desired levels within two years, …


New class of drugs offer alternative to statins

March 14, 2019
Research and Development cholesterol, health, imperial college london, research, statins

A new class of cholesterol lowering drugs may help patients who are unable to take statins, according to a study …


MSD gives up on cholesterol drug, despite positive results

October 12, 2017
Medical Communications, Sales and Marketing MSD, Merck, biotech, cholesterol, drugs, pharma, pharmaceutical

MSD, known as Merck in North America, has revealed that it will not pursue a regulatory filing for its cholesterol …


‘Vaccine’ to lower cholesterol enters human trials

June 20, 2017
Manufacturing and Production, Research and Development AFFiRis, cholesterol, diabetes

After positive results for a ‘vaccine’ to combat fatty deposits in the arteries in mice, the researchers have taken the …


FDA green-lights Alembic’s cholesterol drug

May 15, 2017
Sales and Marketing Alembic, FDA, cholesterol

Alembic Pharmaceuticals has announced that its fenofibric acid delayed-release capsules have been approved by the FDA for reducing high cholesterol …

Pfizer surprises industry by ending development of projected blockbuster

November 1, 2016
Research and Development Pfizer, cholesterol, clinical trials

Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …


Sanofi & Regeneron’s Praluent cholesterol treatment smashes Phase III target

August 30, 2016
Manufacturing and Production, Research and Development Regeneron, Sanofi, apheresis, cholesterol, phase III

Sanofi and Regeneron have announced that their Praluent injection generated positive Phase III results investigating patients with an inherited form …

NICE recommends Sanofi, Amgen cholesterol drugs

May 6, 2016
Medical Communications, Sales and Marketing Amgen, Draft Guidance, NHS, NICE, Repatha, Sanofi, cardiovascular disease, cholesterol, final draft guidance, high cholesterol, praluent, recommendation, treatment

The National Institute for Health and Care Excellence (NICE) has issued final draft guidance recommending two new drugs for the …


Allergan launches Crestor generic in the US

May 3, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, AstraZeneca, Crestor, FDA, FDA Approval, cholesterol, generic, patent, patent expiry, sales

Allergan has received FDA approval on the generic version of AstraZeneca’s high cholesterol drug, Crestor (rosuvastatin), and has become the …


Roche’s cholesterol-lowering drug candidate shows promise in fighting prostate cancer

April 15, 2016
Medical Communications, Research and Development RO 48-9071, Roche, cholesterol, drug, missouri, oncology, university

Researchers from the University of Missouri have found that a compound developed by Roche Pharmaceuticals for the treatment of high …


Amgen wins high-profile cholesterol drug patent case v Sanofi

March 17, 2016
Sales and Marketing Amgen, PCSK9, Regeneron, Repatha, Sanofi, cholesterol, praluent

A Delaware district court jury has ruled in favour of Amgen in an ongoing dispute around patents for cholesterol-lowering drugs …

Latest content